Trial Profile
Dose Response Study Of Lasofoxifene In Postmenopausal Women With Osteoporosis (Placebo-Controlled, Multicenter, Double-Blind, Comparative Study) - Japanese Asian Dose Evaluation: JADE.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Lasofoxifene (Primary)
- Indications Menopause; Postmenopausal osteoporosis
- Focus Therapeutic Use
- Acronyms JADE
- 18 Jul 2011 Company added as trial sponsor as reported by ClinicalTrials.gov.
- 23 Feb 2010 Official Title amended as reported by ClinicalTrials.gov.
- 23 Feb 2010 Actual patient number (497) added as reported by ClinicalTrials.gov.